Nkarta Therapeutics is Biotechnology in United States that focus on engineered natural killer business. Founded in 2015. They cover business area such as Nkarta Inc, engineer natural killer (NK) cell, cancer, nk cell, abnormal cell, adaptive immune effector, response, its nk expansion platform technology, proprietary cell engineering technology, tumor target, persistence, sustained activity, South San Francisco, California, one segment.
2015
( 9 years old in 2024 )
Engineered Natural Killer
-
6000 Shoreline Court
Suite 102
South San Francisco, CA 94080
United States
Private
Nkarta Incengineer natural killer (NK) cellcancernk cellabnormal celladaptive immune effectorresponseits nk expansion platform technologyproprietary cell engineering technologytumor targetpersistencesustained activitySouth San FranciscoCaliforniaone segment
* We use standard office opening hours in near Nkarta Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nkarta Therapeutics is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Nkarta Therapeutics business is focusing on Engineered Natural Killer.
Nkarta Therapeutics headquarter office and corporate office address is located in 6000 Shoreline Court Suite 102 South San Francisco, CA 94080 United States.
Nkarta Therapeutics was founded in United States.
In 2024, Nkarta Therapeutics is currently focus on engineered natural killer sector.
Above is snippet of Google Trends for "engineered natural killer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nkarta Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
